DAVID JOHNSON: Open Payments
NPI 1750788360 · CORYDON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 35 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $192 |
| Novo Nordisk Inc | 5 | $82 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| CSL Behring | 3 | $71 |
| ABBVIE INC. | 3 | $54 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Exact Sciences Corporation | 2 | $40 |
| Medtronic, Inc. | 1 | $27 |
| Corium, LLC | 2 | $25 |
Products named: BREZTRI, REXULTI, Rybelsus, Andembry, Auvelity, TRELEGY ELLIPTA, VRAYLAR, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
